NuFund Venture Group — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Kneevoice develops a non-invasive cartilage auscultation device that captures knee joint sounds, vibrations, and position data to assess cartilage damage for use by medical providers and physical therapists.
AI & Machine LearningHealthtechMedical DevicesSanta Monica, US
Gustavo De Greiff(Executive Officer, Director)Carlos Leal(Director)Felipe Rigby(Director)
Co-investorsTechstars
Vasa Therapeutics is a biopharmaceutical company focused on discovering and developing therapeutics that target the pathophysiology of cardiovascular aging.
BiotechLongevity
Co-investorsi&i Biotech Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


